PREVALENCE OF DRUG HYDROXYLATOR PHENOTYPES IN BELGIUM

被引：11

作者：

LECLERCQ, V ^{[1
]}

DESAGER, JP ^{[1
]}

VANNIEUWENHUYZE, Y ^{[1
]}

HARVENGT, C ^{[1
]}

机构：

[1] CATHOLIC UNIV LOUVAIN,PHARMACOTHERAPIE LAB,53 AVE E MOUNIER,B-1200 BRUSSELS,BELGIUM

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 33卷 / 04期

关键词：

D O I：

10.1007/BF00637647

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：439 / 440

页数：2

共 7 条

[1]

ALVAN G, 1982, LANCET, V2, P333

[2] THE GENETIC-CONTROL OF BUFURALOL METABOLISM IN MAN [J].

DAYER, P ;

BALANT, L ;

COURVOISIER, F ;

KUPFER, A ;

KUBLI, A ;

GORGIA, A ;

FABRE, J .

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1982, 7 (01) :73-77

[3] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].

EICHELBAUM, M ;

SPANNBRUCKER, N ;

STEINCKE, B ;

DENGLER, HJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187

[4]

EICHELBAUM M, 1986, ACTA PHARMACOL TOX, V59, P44

[5] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].

EVANS, DAP ;

MAHGOUB, A ;

SLOAN, TP ;

IDLE, JR ;

SMITH, RL .

JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105

[6] GENETICALLY-DETERMINED POLYMORPHISMS IN DRUG OXIDATION [J].

JACQZ, E ;

HALL, SD ;

BRANCH, RA .

HEPATOLOGY, 1986, 6 (05) :1020-1032

[7] DETERMINATION OF DEBRISOQUINE AND ITS 4-HYDROXY METABOLITE IN BIOLOGICAL-FLUIDS BY GAS-CHROMATOGRAPHY WITH FLAME-IONIZATION AND NITROGEN-SELECTIVE DETECTION [J].

LENNARD, MS ;

SILAS, JH ;

SMITH, AJ ;

TUCKER, GT .

JOURNAL OF CHROMATOGRAPHY, 1977, 133 (01) :161-166

← 1 →